Cite
HARVARD Citation
Ke, B. et al. (n.d.). DOP33 Single-cell analysis identifies pathological fibroblasts as a new therapeutic target to prevent intestinal fibrosis in Crohn's disease. Journal of Crohn's and colitis. pp. i96-i97. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Ke, B. et al. (n.d.). DOP33 Single-cell analysis identifies pathological fibroblasts as a new therapeutic target to prevent intestinal fibrosis in Crohn's disease. Journal of Crohn's and colitis. pp. i96-i97. [Online].